The global tumor genomics market is expected to reach a market size of 56.54 Billion by 2028 and register a double-digit CAGR over the forecast period, according to latest analysis by Emergen Research. The steady projected growth can be attributed to technological innovations in the field of genomics. Mergers and acquisitions between key players in the field is another key factor driving market growth. Increasing research on cancer, usage of genomic systems among academics and government institutions, and decreasing cost of sequencing is contributing significantly to growth in cancer diagnostics. Moreover, advances in computational approaches in tumor genomics has resulted in shorter result time, which is a key factor driving adoption, and thus driving growth of the market. Tumor is often caused by genetic alterations, including gene fusions, large chromosomal rearrangements; however, next generation sequencing techniques have helped researchers gather vast amounts of tumor genomic data and record genetic mutations in various cancer types.
https://www.emergenresearch.co....m/industry-report/tu
![image](https://s1.vsetistorage.ru/upload/photos/2023/01/KXf3zub1xZkqsD2DfPId_03_5a39509b3278cccd373bcc5fa6aa3fdc_image.jpg)